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Aspirin–cholesterol interactionAspirin and other non-steroidal anti-inﬂammatory drugs have a high afﬁnity for phospholipidmembranes, alter-
ing their structure and biophysical properties. Aspirin has been shown to partition into the lipid head groups,
thereby increasing membrane ﬂuidity. Cholesterol is another well known mediator of membrane ﬂuidity, in
turn increasing membrane stiffness. As well, cholesterol is believed to distribute unevenly within lipid mem-
branes leading to the formation of lipid rafts or plaques. Inmany studies, aspirin has increased positive outcomes
for patients with high cholesterol. We are interested if these effects may be, at least partially, the result of a non-
speciﬁc interaction between aspirin and cholesterol in lipid membranes.
We have studied the effect of aspirin on the organization of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine
(DPPC) membranes containing cholesterol. Through Langmuir–Blodgett experiments we show that aspirin in-
creases the area per lipid and decreases compressibility at 32.5mol% cholesterol, leading to a signiﬁcant increase
of ﬂuidity of the membranes. Differential scanning calorimetry provides evidence for the formation of meta-
stable structures in the presence of aspirin. The molecular organization of lipids, cholesterol and aspirin was
studied using neutron diffraction. While the formation of rafts has been reported in binary DPPC/cholesterol
membranes, aspirinwas found to locally disruptmembrane organization and lead to the frustration of raft forma-
tion. Our results suggest that aspirin is able to directly oppose the formation of cholesterol structures through
non-speciﬁc interactions with lipid membranes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Lateral heterogeneity in lipid composition in membranes permits
the existence of so-called lipid rafts: regions of the membrane believed
to contain elevated cholesterol composition and increased molecular
order [1–4]. Domains serve a functional purpose as they are thought
to take part in membrane-associated events such as lipid/protein
sorting and signal transduction, among other roles [5–10]. Experimental
observation of rafts has been challenging as they are believed to be both
small and short lived [11–14].
Cholesterol is suggested to drive domain formation through lipid in-
teractions with cholesterol's stiff ring structure leading to the so-called; ASA, acetylsalicylic acid; DSC,
tt; PG, pyrolytic graphite; TFE,
se
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nstädter).liquid ordered (lo) phase [15–18]. Small, transient cholesterol domains
in binary lipid bilayers at physiological levels of cholesterolwere recent-
ly reported from computer simulations and experiments [18–23]. At
high concentrations of cholesterol, above ~40 mol%, immiscible
cholesterol bilayers were reported to form spontaneously in model
lipid bilayers [24–28].
There is growing evidence for an inﬂuence of various pharmaceuti-
cals on lipid membrane organization and stability [29]. In particular,
non-steroidal anti-inﬂammatory drugs (NSAID's) have been shown to
disturb bilayer structures in real andmodel membranes [30,31]. Aspirin
(acetylsalicylic acid, ASA) is the most common NSAID and has been
shown to have strong interactions with bilayer structures [30,32]. Aspi-
rin strongly perturbs model membrane structures in a concentration
dependent manner and inﬂuences human erythrocyte shape [33]. As
well, aspirin decreases the hydrophobic surface barrier in mucosal
membranes, leading to a diffusion of acid and gastrointestinal injury
[34] and has an effect on protein sorting [35]. Recently, a direct interac-
tion between aspirin and cholesterol was reported as aspirin was
observed to reduce the volume of cholesterol plaques in model
membranes with elevated cholesterol concentrations of 40 mol% [36].
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levels of cholesterol has not been explored.
We examined the effect of aspirin onmembranes composed of DPPC
and physiological levels of cholesterol. The molecules are depicted in
Fig. 1. By combining Langmuir–Blodgett isotherms, calorimetric
measurements and neutron diffraction, we present evidence that the
presence of 10 mol% ASA leads to a signiﬁcant re-ﬂuidiﬁcation of
DPPC/32.5 mol% cholesterol bilayers. The neutron diffraction patterns
are indicative of ASA super-structures in the ﬂuid bilayers, which
seem to frustrate the formation of cholesterol rafts.2. Results
2.1. Langmuir–Blodgett monolayer compression isotherms
Pressure versus area isotherms were recorded for DPPC monolayers
with andwithout cholesterol in order to determinemolecular areas and
compressibility. ASAwas dissolved in the aqueous sub-phase at concen-
trations of 0 mM and 3 mM. All experiments were performed with a
sub-phase temperature of 50 °C. Fig. 2a) shows the compression iso-
therms for all experiments. The addition of 32.5 mol% cholesterol to
the monolayer shifts the isotherm towards lower pressures and lower
area per lipid compared to a monolayer composed of pure DPPC. How-
ever, with the addition of 3mMASA into thewater sub-phase, the com-
pression isotherm shifted to higher pressures and higher area per lipid,
for both pure DPPC monolayers and monolayers containing 32.5 mol%
cholesterol. To best capture trends observed in the compression iso-
therms, a pressure of 27 mN/m was chosen to compare the changes in
the monolayer area per molecule as well as in the compressibility
modulus due to the incorporation of cholesterol and ASA.
The meanmolecular area for all isotherms at a pressure of 27mN/m
is plotted in Fig. 2b). At this pressure, a DPPCmonolayer has amean area
of AL=71.9± 0.5 Å2. The addition of 32.5 mol% cholesterol to the DPPC
monolayers decreases AL signiﬁcantly to 38.6 ± 0.2 Å2. Inclusion of
3 mM ASA in the sub-phase leads to an increase of the area per lipid
to 74.4 ± 0.7 Å2. The same effect is observed in the presence of choles-
terol: the addition of 3 mM ASA in the sub phase leads to a signiﬁcant
increase of the area per lipid in DPPC/32.5 mol% cholesterol from
38.6 ± 0.2 Å2 to 44.3 ± 0.3 Å2.
The compressibility of the monolayers is determined by the slope of
the isotherms (as detailed in the Materials and methods section,
Section 4). The addition of ASA to the water sub-phase decreases the
elastic compressibility modulus, CS−1, from 84 ± 1 mN/M for pure
DPPC to 63 ± 1 mN/M for DPPC/3 mM ASA as depicted in Fig. 2c), at a1,2-dipalmitoyl-sn-glycero-3-phosp
Acetylsalicyclic acid (ASA)
Fig. 1. Schematic representations of the 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (pressure of 27 mN/m. This is in strong contrast to cholesterol, which
increases the compressibility modulus when added to the monolayer
from 84 ± 1 mN/M to 89.8 ± 0.3 mN/M, as reported previously
[37,38]. Addition of ASA to the DPPC/32.5 mol% cholesterol monolayers
reduces the compressibility from 89.8 ± 0.3 mN/M to 80.6 ± 0.5 mN/M.
A decreased compressibility modulus is indicative of membranes,
which are softer and more compressible. The increase in molecular
area and decrease in compressibility for a pure DPPC bilayer in the pres-
ence of aspirin points to a general increase in ﬂuidity of themembranes.
The increase in molecular area and decrease in compressibility for
DPPC/32.5 mol% cholesterol bilayers is strong evidence for a re-
ﬂuidiﬁcation of the bilayers at a physiological cholesterol concentration
with ASA.2.2. Differential scanning calorimetry
The effect of ASA on the phase behavior of membranes was exam-
ined using differential scanning calorimetry. Multi-lamellar vesicles
(MLVs) of different composition were prepared for these experiments.
Heating thermograms are plotted in Fig. 3a). A thermogram taken
from a pure DPPC sample shows two endothermic transitions. There is
a pre-transition from the gel to ripple phase (Lβ→Pβ0 ) at T ~ 308 K.
Themain transition to the ﬂuid phase (Lα) occurs at 314K, in agreement
with literature values [39]. Addition of ASA resulted in a decrease in the
main transition temperature and broadened the main transition peak
(and eliminated the pre-transition). Similar results have been reported
when ASA is added to DMPC liposomes [33]. A reduction or suppression
in transition temperatures and transition enthalpy is evidence that ASA
reduces the cooperativity of themain and pre-transitions, indicative of a
more ﬂuid structure.
As expected, thermograms of samples composed of DPPC with
32.5mol% cholesterol in Fig. 3b) showno transitions, aswas reportedpre-
viously for the lo phase [20,40]. The absence of a transition proves that a
cholesterol concentration of 32.5 mol% is high enough to induce the lo
phase in DPPC bilayers. No change was observed after addition of 1 mM
ASA (data not shown). However, as shown in Fig. 3b), addition of 6 mM
ASA led to the appearance of an exothermic transition at T= 313.6 K.
The bilayers were then cooled and the heating thermogramwas re-
peated. After this second cycling the transition peak shifted to T=308K
and signiﬁcantly broadened. The temperature cyclingwas repeated, and
a third thermogram shows no transition peak. We note that no peak
was observed upon cooling, regardless of cycle number. The depen-
dence of the thermogram upon temperature cycling indicates the
presence of inhomogeneities and kinetically trapped states existing onhatidylcholine (DPPC)
Cholesterol
DPPC), cholesterol, and acetylsalicylic acid (ASA, aspirin) molecules used in this study.
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Fig. 2. Langmuir–Blodgett experiments were performed on DPPC monolayers with and without cholesterol. a) Compression isotherms of monolayers of DPPC (blue), DPPC with 3 mM
ASA in the subphase (green), DPPC/32.5 mol% cholesterol (red) and DPPC/32.5 mol% cholesterol and 3 mM ASA in the subphase (purple). b) Area per lipid molecule for isotherms at
Π= 27 mN/m for all samples. c) Compressibility modulus (CS−1) for all samples, measured atΠ= 27 mN/m.
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point, therefore, to the existence ofmeta-stable structures in cholesterol
bilayers in the presence of ASA, as will be discussed below.
2.3. Neutron diffraction
Lateral molecular order of chain perdeuterated DPPC bilayers con-
taining 32.5 mol% cholesterol and 10 mol% ASA was studied using in-
planeneutrondiffraction. Rafts have been reported at this concentration
of cholesterol in DPPC bilayers from computer simulations and experi-
ments [18–23]. Highly oriented, solid supported membranes were
prepared and placed in a humidity chamber at T=50 °C and a D2O rel-
ative humidity of ~100%, ensuring full hydration of bilayers. Bilayers
made of DPPC/32.5 mol% cholesterol were previously studied using
this setup by Armstrong et al. [20] and dz-spacings of 64 Å were ob-
served, in good agreement with lamellar spacings reported by Gallová
et al. [53] in multi-lamellar DPPC liposomes with 33.3mol% cholesterol.308 310 312 314 316
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Fig. 3.Differential scanning calorimetry studies of multi-lamellar vesicleswith cholesterol
and ASA. a) Heating scans of pure DPPCmembranes with different ASA concentrations in
the aqueous phase. b) Heating scans of DPPCmembraneswith 32.5mol% cholesterol.With
no ASA in the sub-phase, a heating scan shows no feature indicating membranes with
32.5 mol% cholesterol are in the lo phase. However, addition of 6 mM ASA leads to the ap-
pearance of an additional feature, which is unstable upon repeated heating scans.This proves that fully hydrated bilayers can be prepared using our
technique.
Two different neutron scattering setups were used: (1) a conven-
tional high energy andmomentum resolution setup and (2) a low ener-
gy and momentum resolution setup, which permits greater spatial
resolution for detecting small structures and weak signals, as reported
previously [20,23,44,45]. The two setups were achieved by changing
the incoming neutron wavelength, λ, without any need to re-align the
sample or change the hydration state of the bilayers. By using chain
perdeuterated DPPC-d62, our experiment was predominantly sensitive
to molecular structure and arrangement of the lipid acyl chains. The
samplewas aligned in the neutron beam such that the scattering vector,
Q
!
, was always in the plane of themembranes. This in-plane component
of the scattering vector is referred to as q||.
Data taken using the conventional setup is shown in Fig. 4a). Sharp
peaks occur at q|| = 1.1 Å−1 and 1.65 Å−1, which are assigned to scatter-
ing from silicon (in higher orders) and are highlighted in gray. The0
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Fig. 4. In-plane neutron diffraction proﬁles of DPPC-d62membranes containing 32.5mol%
cholesterol and 10mol%ASA. a) An in-planeproﬁle recordedwith a typical low spatial res-
olution setup. The sharp gray peaks at q|| = 1.1 Å−1 and 1.65 Å−1 originate, respectively,
from 3rd and 2nd order scattering of silicon. The single feature, typically observed in dif-
fraction patterns, is a broad correlation peak due to the packing of the lipid tails in the hy-
drophobic membrane core. b) An in-plane proﬁle recorded with a high spatial resolution
setup. Additional, narrow and pronounced features appear with change in resolution, as
explained in the text.
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Fig. 5.Cartoon of a DPPCmembrane containing 32.5mol% cholesterol and 10mol% ASA, as
deduced from the neutron diffraction data in Fig. 4a). A depiction of a bilayer containing
cholesterol and ASA. b) A cartoon of the super-lattice as imaged by the high spatial reso-
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indicated in blue. The broad correlation peak was well described by a
Lorentzian peak proﬁle, and was previously assigned to a hexagonal
packing of the lipid acyl chains in the hydrophobic membrane core
with parameters alipid−lo = blipid−lo = 5.58 Å and γ= 120° [20,23]. The
data in Fig. 4a) show a diffraction pattern typical of a ﬂuid, liquid-
ordered (lo) membrane.
The diffraction pattern obtained using a high spatial resolution is
shown in Fig. 4b). In addition to a broad correlation peak and sharp
peaks originating from silicon, three narrow and pronounced correla-
tion peaks are visible, indicating a coexisting and well-ordered lateral
structure. The broad correlation peak at q|| ~ 1.36 Å−1 is no longer
well described by a single distribution. Rather, two Lorentzian proﬁles
were required to ﬁt the observed scattering: (1) a peak located at
q|| ~ 1.37 Å−1 (in agreement with part a)); and (2) a weaker peak at
q|| ~ 1.28 Å−1. The latter is highlighted by the green proﬁle in Fig. 4b).
The observation of two peak proﬁles suggests the presence of two envi-
ronments for the lipid tails in the presence of ASA. The integrated area of
the green Lorentzian at smaller q||-values in Fig. 4b) is ~1/3 the integrat-
ed area of the blue proﬁle. The concentration of ASA and DPPC in the bi-
layers is 10 mol% and 60.75 mol% respectively, resulting in a ratio
between ASA and lipid molecules of ~1/6. The ratio between the inte-
grated intensities is then indicative that one ASA molecule interacts
with two lipid molecules leading to a lipid environment with a larger
tail spacing.
The position of the sharppeaks (q||=0.305 Å−1, q||=0.41 Å−1, q||=
0.705Å−1) are best indexed by the [100], [110] and [020] reﬂections, re-
spectively, of amonoclinic unit cell with parameters asuperlattice=21.2 Å,
bsuperlattice = 18.2 Å, γ= 104°. The dimensions of the unit cell suggest
the formation of a super-lattice-type structure, containing several lipid
and cholesterol molecules. The corresponding molecular structure is
depicted in Fig. 5. We note that the diffraction pattern in Fig. 4b) does
not show evidence for the highly ordered, monoclinic lipid raft struc-
ture, which was observed previously by Armstrong et al. in DPPC/
32.5 mol% cholesterol bilayers through neutron diffraction.lution setup. The black arrows highlight a super-lattice cell, determined from the diffrac-
tion pattern in Fig. 4b). The different lipid environments are highlighted by the green
and red parallelograms.3. Discussion and conclusions
When introduced into the body, aspirin and its metabolites are
understood to interact through speciﬁc biochemical reactions. Aspirin
is known to interact with the cyclo-oxygenase (COX) pathway. The in-
hibition of both COX isoforms, COX-1 and COX-2, by higher dose aspirin
is believed to lead to analgesic and anti-inﬂammatory effects, while
lower doses, sufﬁcient to inhibit COX-1 activity, leads to anti-platelet ac-
tivity [46,47]. However, there is evidence for the role of platelet mem-
brane composition and ﬂuidity in determining platelet cell function
[48–50]. Platelet aggregation has also been associated with lipid rafts
[51]. As discussed in the Introduction, there is growing evidence for an
interaction of aspirin with lipid membranes through non-speciﬁc
effects.
As a prerequisite for such non-speciﬁc interactions, aspirin was re-
ported to partition into lipid bilayers and position itself in the lipid
head group region [32,36]. Our experiments suggest that aspirin is
able to directly interact with model lipid membranes and oppose the
molecular level organization induced by cholesterol.
We studied the interaction between DPPC bilayers containing
32.5 mol% cholesterol and ASA using three different techniques, namely
Langmuir–Blodgett experiments, differential scanning calorimetry and
neutron diffraction. At this physiological cholesterol concentration, the
DPPC bilayers are in their liquid-ordered phase. The lo phase in binary
DPPC/cholesterol bilayers was recently reported to form rafts [18–23]
from experiments and simulations.
In order to use the different experimental techniques, different sys-
tems were prepared: monolayers were used in the Langmuir–Blodgett
experiments, fully hydrated multilamellar vesicles in the calorimetricexperiments and highly oriented solid supportedmultilamellar bilayers
hydrated through the vapor phase in the neutron diffraction experi-
ments. We note that the area per molecule in the lipid monolayers of
~72 Å2 is larger than the area per lipid reported for multilamellar
DPPC bilayers of ~64 Å2 [52]. The lamellar spacing that we determine
at ~57 Å is signiﬁcantly lower than the dz-spacing of ~65 Å reported
for fully DPPC/32.5mol% cholesterol bilayers [20,53].Whilewe attribute
the reduction in dz-spacing mainly to the presence of ASA in the bilay-
ers, we cannot exclude that the bilayers in our study did not achieve
full hydration, as no reference values are published in the literature.
Nevertheless, qualitatively similar results were observed when ASA
was added to each of the systems: the bilayers showed an increase in
ﬂuidity and the effects of cholesterol are countered. We, therefore, can
argue that the conclusions we draw below are robust and supported
by the experiments.
10 mol% ASA was added to the membranes, i.e., 1 ASA molecule per
10 lipid molecules. This ASA concentration is elevated as compared to
plasma concentrations of less than 1 mol%, however, comparable to
ASA concentrations typically used in the literature [54]. Floating mono-
layers were used to determine the area per molecule and compressibil-
ity in the presence of ASA. Multi-lamellar vesicles were studied in the
calorimetric experiments to determine the effect of ASA on the phase
behavior. Finally, solid supported bilayerswere used for neutron diffrac-
tion experiments to study arrangement of themolecules in the plane of
the membranes.
Several conclusions can be drawn from this combination of
techniques and systems. ASA interacts with monolayers, vesicles and
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ﬁrst and ASA was added to the aqueous phase (monolayers and vesi-
cles) or included in themembranes at the time of the bilayer formation
(solid supported bilayers). From the trough experiments, ASA leads to
an increase in the area per molecule and a decrease in compressibility
in pure DPPC and in DPPC/32.5 mol% cholesterol systems, indicative of
a signiﬁcant ﬂuidiﬁcation of the membranes. We note that ASA was re-
ported previously by Alsop et al. [36] to dissolve cholesterol plaques,
which form at higher cholesterol concentrations above ~40 mol%.
This increase in ﬂuidity is also seen as a loss of cooperativity in the
calorimetric experiments as broadening of the endothermic main tran-
sition in DPPC bilayers [41]. As a ﬁngerprint of the lo-phase, the main
transition is suppressed in DPPC/32.5mol% cholesterol bilayers. Howev-
er, addition of 6 mMASA to the aqueous phase led to the formation of a
meta-stable phase in DPPC/cholesterol bilayers, as evidenced by an exo-
thermic peak in the thermogram upon heating, which was shifted and
eventually disappeared upon temperature cycling. Similar results were
found when a quinoline antibiotic was studied with DPPC membranes
[55], and it was suggested that the inclusion interaction of the drug
with membranes led to the formation of meta-stable structures in the
bilayers. Similar behavior can be observed in orientational glasses
caused by a dynamic domain pattern and often related to aging and
memory effects [56,57].
Neutron diffraction of oriented bilayers, using deuterium labeled lipid
molecules, was used to study potential lateral structures in the presence
of aspirin. Neutron measurements were taken at a constant temperature
of 323 K, as continuous temperature cycling was not possible given the
long counting times required for data collection. At low spatial resolution,
the in-plane neutron diffraction pattern is indicative of a membrane in a
uniform, disordered ﬂuid state as reported previously [20,58,59]. The
broad correlation peak in Fig. 4a) is the result of the hexagonal packing
of the lipid acyl chains in the hydrophobic membrane core (planar
group p6), as reported from, e.g., neutron diffraction [20].
With an increase in spatial resolution the lipid correlation peak is
best described by two Lorentzian peak proﬁles, suggestive of two
short-ranged lipid correlations and corresponding environments. A
small, broad peak at q|| ~ 1.28 Å−1, equivalent of an increased tail spac-
ing, is associated with lipids interacting with aspirin molecules. The ad-
ditional narrow and pronouncedmonoclinic super-lattice peaks are also
driven by the presence of aspirin in the membrane. The corresponding
molecular structure is depicted in Fig. 5. The ASA molecules, and the
interacting lipid molecules, organize in a regular pattern throughout
the membrane. Based on the ratio between the lipid chain peaks in
the neutron data, each ASA molecule associates with two lipid mole-
cules. This structure was observed with a neutron setup, which mea-
sured q|| with qz = 0. We can, therefore, not comment on whether the
observed in-plane superlattice is possibly correlated across bilayers in
the membrane stack.
This structure is different from the structure typically observed in bi-
nary DPPC/cholesterol membranes. While rafts were reported from
computer simulations [19,21,22] and experiments [20,23], the presence
of the ASAmolecules in the bilayers seems to frustrate the formation of
locally ordered cholesterol domains. While correlation peaks corre-
sponding to raft structures were reported from neutron diffraction by
Armstrong et al. [20] and Toppozini et al. [23] in DPPC/32.5mol% choles-
terol, these peaks were not observed in the diffraction data in Fig. 4,
indicative that raft formation is inhibited in the presence of ASA.
In summary, the effect of aspirin (acetylsalicylic acid, ASA) on
the structure of ﬂuid lipid membranes made of DPPC containing
32.5 mol% cholesterol was studied at a concentration of 10 mol% ASA.
Langmuir–Blodgett experiments suggest that ASA interacts with DPPC
monolayers from the aqueous phase and leads to a ﬂuidiﬁcation of
DPPC and DPPC/cholesterol membranes. Signatures of meta-stable pat-
terns were observed in differential scanning calorimetry experiments.
The corresponding molecular structure was determined from neutron
diffraction. The observed diffraction pattern indicates that the presenceof ASA leads to the formation of a super-lattice and the frustration of
highly ordered cholesterol domains that were reported in binary
DPPC/cholesterol membranes previously.
Although an interaction between aspirin and cholesterol was stud-
ied using three different membrane systems, the results in all systems
suggest that ASA is able to counteract the effects of cholesterol when
interacting with ﬂuid lipid membranes. ASA induces changes to both
the domain structure and the mechanical properties of DPPC mem-
branes. These results add to the growing evidence for the potential of
ASA to have a profound inﬂuence on the properties of membranes
through non-speciﬁc interactions.
4. Materials and methods
Lipids and cholesterol were purchased from Avanti Polar Lipids (Al-
abaster, AL) and used without further puriﬁcation. Acetylsalicylic acid
(N99% crystalline) was purchased from Sigma Aldrich (Mississauga,
ON).
4.1. Preparation of Langmuir monolayers and measurement of isotherms
Langmuir isotherms were performed on a KSV NIMA Minitrough
(50 mm× 155 mm) and delrin barriers. Barrier control and data acqui-
sition were achieved using the LB measurement system provided by
KSV NIMA (Biolin Scientiﬁc, Linthicum Heights, Maryland USA). The
balance was calibrated using a 264.9 mg calibration standard provided
by the manufacturer prior to the commencement of the experiments.
Surface pressures were measured using pre-wetted paper Wilhemy
plates at temperatures of 50 °C. Ultrapure (18.2 MΩ cm) water per-
formed the role of the sub-phase. The sub-phase pressure was kept
below 0.1 mN/m prior to spreading the lipid. If the pressure exceeded
0.1 mN/m, the surface was re-cleaned and the procedure repeated.
Phospolipid ﬁlms were spread by careful deposition of 2 μL volumes of
chloroform solution containing 3mg/mL lipid solution. After deposition,
10 min was allotted for solvent evaporation. The compression rate was
5 cm2/min. Two lipid solutions were prepared: a pure DPPC solution,
and a solution composed of DPPC/32.5 mol% cholesterol, both with con-
centrations at 3mg/mL. Sub-phase solutionswith two different concen-
trations of ASA were prepared: 0 mM ASA and 3 mM ASA.
The elastic compressibility can be determined from thepressure ver-
sus area isotherm, by calculating the corresponding slope:
C−1s ¼−A
dπ
dA
 
; ð1Þ
with CS−1 being the compressionmodulus, A the area in the trough and
π the pressure.
4.2. Differential scanning calorimetry
Solutions of DPPC and DPPC with 32.5 mol% cholesterol were pre-
pared in chloroform, then dried. Mixtures were placed under vacuum
for ~6 h to ensure that all residual solvent was removed. Samples
were then hydrated with ultrapure water (18.2 MΩ cm), with ASA con-
centrations of 0 mM, 1 mM and 6 mM to ﬁnal DPPC concentrations of
125 mg/mL. Samples were put through 5 freeze/thaw cycles with
vortexing, ensuring during the thaw step the solutions reached 50 °C.
25 μL of solution was loaded into Shimadzu Aluminum Hermetic Pans
and crimp sealed. Thermograms were collected at 1 °C/min and a
sampling rate of 1 s using a Shimadzu DSC-60 and a TA-60WS Thermal
Analyzer.
4.3. Supported bilayer preparation
Highly oriented bilayers of 1,2-dipalmitoyl-sn-glycero-3-
phosocholine (DPPC) containing cholesterol and acetylsalicylic acid
monochromator analyzer
q||
Table 2
Instrumental parameters of the triple-axis spectrometer.
λ (Å) E (meV) ΔE (meV) ΔQ (Å−1)
2.37 14.6 0.757 0.020
1.49 37.3 3.239 0.032
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Fig. 6. Neutron reﬂectivities measured simultaneously with the in-plane data. Results
from the typical setup are shown in blue, and results from the high spatial resolution
setup are shown in green. The reﬂectivity shows a series of equally spaced and pro-
nounced reﬂections, indicative of a well-ordered multi-lamellar membrane structure.
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coherent scattering of lipid hydrocarbon chains was enhanced using
chain perdeuterated lipids, DPPC-d62. A solution of 16.67 mg/mL of
DPPC-d62 with 32.5 mol% cholesterol and 10 mol% ASA in 1:1 chloro-
formand 2,2,2-triﬂuoroethanolwas prepared. 2 inch circular siliconwa-
fers with a thickness of ~300 μm were cleaned with 12 min alternate
sonications in methanol and ultrapure water (18.2 MΩ cm) at 310 K.
This process was repeated twice. Clean, dry wafers were individually
placed on a 4 in. × 4 in. marble block. The marble block was heated to
323 K, well above the main transition temperature of DPPC, ensuring
that lipids were well in the ﬂuid state during deposition. 1.2 mL of the
lipid solution was deposited on the silicon wafer. Immediately after de-
position, the marble block was manually lifted and gently rocked while
the bulk of the solution evaporated (~1–2 min), to ensure even cover-
age of material.
The wafers were kept under vacuum overnight at 310 K to remove
all traces of solvent. Nineteen such wafers were then stacked with
0.6mmalumium spacers placed in between eachwafer, to ensure prop-
er hydration control. This “sandwich” sample was then placed inside a
sealed container with a beaker of heavy water and placed in an incuba-
tor. The temperature of the incubator was increased in discrete steps
from 300 K to 323 K over a period of 24 h, then held at 323 K and incu-
bated for additional 24 h. Following this procedure, each wafer
contained ~3000 highly oriented stackedmembraneswith a total thick-
ness of ~10 μm.
During the neutron experiment, the sample was sealed in a temper-
ature controlled aluminium chamber (CNBC, Chalk River, Canada).
Hydration of the membranes from the vapor phase was achieved by
separately controlling the temperature of a heavy water bath, the sam-
ple, and the walls of the chamber. Temperature sensors were installed
close to the sample. A circulating water bath was used to control the
temperature of the reservoirs and peltier elements were used to control
the temperature of the sample and chamber. The sample was mounted
vertically in the neutron beam such that the scattering vector, Q
!
, couldTable 1
Peak parameters of the correlation peaks observed in Fig. 4a) and b) and the association
with the observed structures, such as the lo phase, lipids associated with ASA molecules
and the super-lattice driven by the presence of ASA molecules. T1 denotes the unit cell
of the lipid tails in the lo regions of themembrane. TAL denotes the peak assigned to corre-
lations between lipid molecules when inﬂuenced by ASA. Peaks were ﬁtted using
Lorentzian peak proﬁles and the corresponding widths are listed as Lorentzian widths
(HWHM), γL.
Amplitude
(counts)
Center
(Å−1)
γL
(Å-1)
lo ASA bound
lipids
Super-lattice
phase
Fig. 4a) 48 1.36 0.14 T1
Fig. 4b) 85 0.306 0.01 [1 0 0]
89 0.406 0.014 [1 1 0]
50 0.705 0.011 [0 2 0]
14 1.26 0.14 TALeither be placed in theplane of themembrane (q||) or perpendicular to it
(qz). The out-of-plane and in-plane structures could be measured
simply by rotating the sample by 90°.
The lamellar spacing, i.e., the distance between membranes in the
stack, dz, was determined from reﬂectivity scans. The corresponding
out-of-plane or reﬂectivity scans are shown in Fig. 6, and show a series
of pronounced and evenly spaced Bragg peaks indicative of uniform and
well developedmembrane stacks. Scans were performed with different
wavelengths and over the duration of the experiment of two weeks.
During the experiment, the bilayer spacing stayed within the range
55.8 Å and 57.9 Å. This setup has been used before to produce ﬂuid
DPPC bilayers [20,44] with dz-spacings in agreement with literature
values for fully hydrated bilayers of ~64 Å [20,58]. The observed de-
crease in lamellar spacing is most likely the effect of the incorporation
of ASA in the bilayers, in agreement with the increased ﬂuidiﬁcation
found in the trough and calorimetric experiments. The main transition
of DPPC-d62 is reported as 313 K [60,61]. All scans were done with a
sample temperature of 323 K, well above the main transition, in the
ﬂuid phase of the bilayers.4.4. Neutron experiment
Experiments were conducted using the N5 triple axis spectrometer
at the Canadian Neutron Beam Centre (Chalk River, Canada). The
three axis of the spectrometer refer to the axis of rotation of the mono-
chromator, the sample and the analyzer. The incident and ﬁnal wave-
lengths were deﬁned by Bragg reﬂections from pyrolytic graphite (PG)
crystals. The divergence of the beam was controlled by Soller collima-
tors. The energy andmomentum (Q) resolution,ΔE andΔQ, of a neutron
triple axis spectrometer are determined by: (1) the incident energy of
the neutron beam; (2) the divergence of the neutron beam; (3) the
wavelength resolution of the monochromator and analyzer crystal.
Collimation of the beam was held constant during the experiment and
set to (c1-c2-c3-c4): 30-18-28-60 (in minutes). Small and large ΔE
setupswere achieved by varying the incident energy and corresponding
neutron wavelength selected by the monochromator.incoming 
neturon beam
detector
ki kfc1 c4
c2
c3
Fig. 7. A diagram of the setup used for the neutron scattering experiment. The orientation
of the sample was chosen such that the scattering vector, Q
!
, lies in the plane of the mem-
brane and is designated q||. ki and kf are the incident andﬁnal neutronwave vectors. The c's
indicate the collimation of the neutron beam at various stages. The resolution of the
experiment is changed by rotating the monochromating crystal and selecting a different
neutron wavelength.
811R.J. Alsop et al. / Biochimica et Biophysica Acta 1848 (2015) 805–812The instrumental parameters for the two setups used in this experi-
ment are listed in Table 2. Energy and Q-resolution (given as FWHM)
were calculated using the ResLib software package by A. Zheludev [62]
adapted to the N5 spectrometer. The longitudinal coherence length of
the neutron beam, ξ, is deﬁned by ξ= λ2/Δλ.
While small collimation was used, the beam size was set to 2 in. by
2 in. to optimally illuminate the silicon wafers, leading to a signiﬁcant
scattering contribution at small Q-values, close to the direct beam.
This background was accounted for by a Lorentzian peak centered at
q||= 0Å−1 including a constant. In contrast to coherent scattering, inco-
herent scattering is isotropic, Q-independent and well accounted for by
a constant background at larger Q-values of Q ≳ 0.45 Å−1. After back-
ground subtraction, the observed peaks were ﬁt with Lorentzian pro-
ﬁles using a least squares method, and the results plotted in Fig. 4,
with the ﬁtting parameters presented in Table 1.
Switching between the high and low energy resolution setups was
done by simply changing λ. A smaller neutron wavelength leads to
strongly relaxed ΔQ and ΔE. In addition, the longitudinal coherence
length of the neutron beam decreases. Themost signiﬁcant changes be-
tween the high and low energy resolution setups are: (1) a more efﬁ-
cient integration over larger q|| ranges to enhance small signals; and
(2) a reduction of the coherently added scattering volume. A diagram
of the scattering geometry for the in-plane measurements is depicted
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